BernardMossMDPh.D.

NIH Distinguished Investigator, Chief Laboratory of Viral Diseases

Dr. Moss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

65 citations
Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model.
Jeffrey L Americo, Patricia L Earl, Bernard Moss
Proceedings of the National Academy of Sciences of the United States of America. 2023-02-21
10 citations
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
Lalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, Kimberly Wilkins, Cynthia S Goldsmith
Plos Pathogens. 2022-10-01
15 citations
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
Jeffrey L Americo, Catherine A Cotter, Patricia L Earl, Ruikang Liu, Bernard Moss
Proceedings of the National Academy of Sciences of the United States of America. 2022-06-14

Journal Articles

RNA Polymerase Mutations Selected During Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replac...
Bernard Moss, MD, mBio

Moving TargetSeptember 16th, 2022
GeoVax Announces Issuance of Hepatitis B Vaccine PatentJuly 7th, 2021
GeoVax Receives Notice of Allowance for Hepatitis B Vaccine PatentApril 1st, 2021
Join now to see all